EUVIMEDEUVIMED entdecken
Crossref

LncRNA SNHG1 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression

Linsen Jiang, Anning Qi, Hongyu Yang, Shuping Wang iD, Fei Wang, Xuemei Bai, Juan Ren

APMIS · 2024

DOI: 10.1111/apm.13410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2024. Verfasst von Linsen Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Biomarkers, Disease Progression, Leukocytes, Mononuclear, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LncRNAs play an important role in autoimmune diseases. The purpose of this study was to explore the role of lncRNA SNHG1 in systemic lupus erythematosus (SLE), and laid a theoretical foundation for the study of SLE. The basic clinical information of all subjects was first collected for statistical analysis, and SNHG1 expression in the serum of all subjects was detected by RT‐qPCR. The value of SNHG1 in the diagnosis of SLE was assessed by ROC. The correlation between SNHG1 and each blood sample index was analyzed by Pearson correlation analysis. The role of SNHG1 in primary peripheral blood mononuclear cells (PBMCs) apoptosis was explored. SNHG1 expression is relatively upregulated in patients with SLE compared to healthy people. SNHG1 expression was positively correlated with SLEDAI score, IgG, CRP, and ESR, and negatively correlated with C3 and C4. ROC indicated that SNHG1 has the potential to assist in the diagnosis of SLE. PBMCs apoptosis in SLE was higher than that in control group, the knockdown and overexpression of SNHG1 could correspondingly inhibit and promote PBMCs apoptosis. SNHG1 has the potential to be a diagnosis marker for SLE and may be involved in regulating PBMCs apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersDisease ProgressionLeukocytes, MononuclearLupus Erythematosus, SystemicRNA, Long NoncodingAdultFemaleHumansMaleMiddle AgedYoung AdultApoptosisROC Curve

Stichwörter der Autor:innen

SNHG1apoptosisdiagnosissystemic lupus erythematosus

Substanzen

Biomarkerslong non-coding RNA SNHG1, humanRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Laboratory, Nanjing LuHe People's Hospital, Nanjing, China.
  • Department of Clinical Laboratory, Affiliated Hospital of PanZhiHua University, Panzhihua, China.

ORCID-Profile: Shuping Wang

Zitieren

APA

Jiang, L., Qi, A., Yang, H., Wang, S., Wang, F., Bai, X., & Ren, J. (2024). LncRNA SNHG1 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression. APMIS. https://doi.org/10.1111/apm.13410

Vancouver

Jiang L, Qi A, Yang H, Wang S, Wang F, Bai X, et al. LncRNA SNHG1 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression. APMIS. 2024. doi:10.1111/apm.13410

BibTeX
@article{Jiang2024,
  author = {Jiang, Linsen and Qi, Anning and Yang, Hongyu and Wang, Shuping and Wang, Fei and Bai, Xuemei and Ren, Juan},
  title = {LncRNA SNHG1 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression},
  journal = {APMIS},
  year = {2024},
  doi = {10.1111/apm.13410}
}
Kostenlos starten →